Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 7, 2017
Lipocine Announces Financial and Operational Results for the Second Quarter and Six Months Ended June 30, 2017
SALT LAKE CITY, Aug. 07, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced financial results for the three and six ...
August 7, 2017
CymaBay to Report Second Quarter 2017 Financial Results on Thursday, August 10
NEWARK, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
August 7, 2017
Rexahn Pharmaceuticals Reports Second Quarter 2017 Financial and Operational Results
ROCKVILLE, Md., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment ...
August 7, 2017
AIT Therapeutics Announces Enrollment of First Patient into Its NO-NTM abscessus Phase 2 Trial in Nontuberculous Mycobacteria (NTM)
REHOVOT, Israel and NEW YORK, Aug. 07, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical-stage anti-microbial therapeutic company treating respiratory diseases with nitric ...
August 7, 2017
CYTOVIA Inc., IMMUNE Pharma’s Oncology Subsidiary, Announces the Publication of New Results in the British Journal of Haematology and Filing of a World-wide Patent Protecting the Use of Ceplene® in Chronic Myeloid Leukemia (CML)
NEW YORK -- (BUSINESS WIRE) -- Cytovia, the oncology subsidiary of Immune Pharmaceuticals (IMNP) ("Immune" or the “Company”), a clinical stage biopharmaceutical company, today announced the ...
August 7, 2017
Gemphire to Present at the Canaccord Genuity Growth Conference 2017
LIVONIA, Mich., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
August 4, 2017
Investors want more women, minorities on corporate boards
What do Amazon, Facebook, and Netflix have in common? Not a single person of color sits on their corporate boards. For that reason alone, the ...
August 3, 2017
Arrowhead Reports Fiscal 2017 Third Quarter Results
PASADENA, Calif.-- (BUSINESS WIRE) -- Arrowhead Pharmaceuticals, Inc. (ARWR), today announced financial results for its fiscal 2017 third quarter ended June 30, 2017. The company is ...
August 3, 2017
Achaogen Reports Second Quarter 2017 Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant ...
August 3, 2017
TherapeuticsMD Announces Second Quarter 2017 Financial Results
BOCA RATON, Fla.-- (BUSINESS WIRE) -- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced its financial results for the quarter ended June ...
August 3, 2017
Mirati Therapeutics Reports Second Quarter 2017 Financial Results
SAN DIEGO, Aug. 3, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX), a clinical stage oncology biotechnology company, reported financial results for the second quarter 2017. ...
August 3, 2017
MediWound Reports Second Quarter 2017 Financial Results
YAVNE, Israel, Aug. 03, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
August 3, 2017
Minerva Neurosciences Reports Second Quarter 2017 Financial Results and Business Updates
WALTHAM, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
August 3, 2017
Catalyst Biosciences Reports Second Quarter 2017 Financial Results and Provides Subcutaneous (SQ) Hemophilia Program Update
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today announced financial results for the second quarter ended June 30, ...
August 3, 2017
Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101
REHOVOT, Israel, and BRIDGEWATER, New Jersey, Aug. 3, 2017 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical stage specialty pharmaceutical company focused on developing and ...
August 3, 2017
Bellerophon Announces FDA Agreement on Phase 2b Study Design for INOpulse® in Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
WARREN, N.J., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH), a clinical-stage biotherapeutics company, today announced agreement with the U.S. Food and Drug Administration ...
August 3, 2017
Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts
Genkyotex (GKTX.PA) (GKTX.PA) (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announced today that data in multiple ...
August 2, 2017
Paratek Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial Results and Provides Clinical Update
BOSTON, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
August 2, 2017
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
LONDON, Aug. 2, 2017 /PRNewswire/ -- Based on its recent analysis of the blood purification market, Frost & Sullivan recognizes CytoSorbents Corporation with the 2017 Global ...
August 2, 2017
Sierra Oncology to Present at the 2017 Wedbush PacGrow Healthcare Conference
VANCOUVER, Aug. 2, 2017 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) ...
Page 111 of 128